Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fuji
Cerilliant
Deloitte
McKesson
Johnson and Johnson
Chinese Patent Office
US Army
Medtronic

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020195

« Back to Dashboard

NDA 020195 describes FENTANYL, which is a drug marketed by Cephalon, Abbott, Hospira, Watson Labs, Actavis Labs Fl Inc, Par Pharm, Specgx Llc, Astrazeneca, Watson Labs Inc, West-ward Pharms Int, 3m Drug Delivery, Actavis Labs Ut Inc, Aveva, Lavipharm Labs, Mayne Pharma, Mylan Technologies, and Noven, and is included in twenty-four NDAs. Additional details are available on the FENTANYL profile page.

The generic ingredient in FENTANYL is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Summary for 020195
Tradename:FENTANYL
Applicant:Cephalon
Ingredient:fentanyl citrate
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TROCHE/LOZENGE;ORALStrengthEQ 0.2MG BASE
Approval Date:Oct 4, 1993TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TROCHE/LOZENGE;ORALStrengthEQ 0.3MG BASE
Approval Date:Oct 4, 1993TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TROCHE/LOZENGE;ORALStrengthEQ 0.4MG BASE
Approval Date:Oct 4, 1993TE:RLD:No

Expired US Patents for NDA 020195

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon FENTANYL fentanyl citrate TROCHE/LOZENGE;ORAL 020195-003 Oct 4, 1993 ➤ Sign Up ➤ Sign Up
Cephalon FENTANYL fentanyl citrate TROCHE/LOZENGE;ORAL 020195-001 Oct 4, 1993 ➤ Sign Up ➤ Sign Up
Cephalon FENTANYL fentanyl citrate TROCHE/LOZENGE;ORAL 020195-007 Oct 30, 1995 ➤ Sign Up ➤ Sign Up
Cephalon FENTANYL fentanyl citrate TROCHE/LOZENGE;ORAL 020195-002 Oct 4, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Cerilliant
Covington
Cantor Fitzgerald
Boehringer Ingelheim
Chinese Patent Office
US Department of Justice
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.